Redfield Robert (CIK 2018274) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-16). Recent activity: Buy TRAW (16,419 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-16 | Traws Pharma, Inc. (TRAW) | Chief Medical Officer | Buy | 16,419 | $0 |
Source: SEC Form 4 filings · as of 2025-12-16